Embecta (EMBC) Return on Capital Employed (2021 - 2026)
Embecta (EMBC) reported Return on Capital Employed of 33.63% for Q1 2026, up 1379.0% on a YoY basis from 2.27% in Q1 2025, and down 4.48% sequentially from 35.21% in Q4 2025.
Embecta (EMBC) Return on Capital Employed (2021 - 2026) Analysis & Trends
Embecta (EMBC) has 6 years of Return on Capital Employed data on file, last reported at 33.63% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 1379.0% year-over-year to 33.63%; the trailing twelve-month figure through Mar 2026 stood at 33.63% (up 1379.0% YoY), and the FY2025 full-year result was 26.13%, up 708.0% from the prior year.
- Return on Capital Employed declined to 33.63% in Q1 2026, from 35.21% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 73.97% in Q1 2022 to a low of 16.32% in Q4 2024.
- A 5-year average of 30.63% and a median of 25.18% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed plunged 4577 bps in 2023 and surged 1889 bps in 2025, its largest moves.
- Tracing EMBC's Return on Capital Employed over 5 years: stood at 36.53% in 2022, then plunged by 45 bps to 20.03% in 2023, then retreated by 19 bps to 16.32% in 2024, then soared by 116 bps to 35.21% in 2025, then decreased by 4 bps to 33.63% in 2026.
- Business Quant data shows EMBC's Return on Capital Employed at 33.63% in Q1 2026, 35.21% in Q4 2025, and 28.07% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 28.56% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 18.58% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 5.02% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 25.95% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.71% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.68% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 19.44% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 12.74% |
| 10 | Embecta | 192.72 Mn | -678,250.00 | 127.80 Mn | 33.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.63% |
| Dec 31, 2025 | 35.21% |
| Sep 30, 2025 | 28.07% |
| Jun 30, 2025 | 24.54% |
| Mar 31, 2025 | 19.84% |
| Dec 31, 2024 | 16.32% |
| Sep 30, 2024 | 18.48% |
| Jun 30, 2024 | 19.28% |
| Mar 31, 2024 | 18.01% |
| Dec 31, 2023 | 20.03% |
| Sep 30, 2023 | 25.18% |
| Jun 30, 2023 | 22.80% |
| Mar 31, 2023 | 28.20% |
| Dec 31, 2022 | 36.53% |
| Sep 30, 2022 | 40.36% |
| Jun 30, 2022 | 60.27% |
| Mar 31, 2022 | 73.97% |
| Dec 31, 2021 | 80.10% |